Raltegravir Approved in Scotland

摘要

On 10 May 2010, the Scottish Medicines Consortium (SMC) announced that raltegravir (Isentress) had been accepted for restricted use withinNHS Scotland for using in combination for adult patients.The indication included not only in the context of drug resistance to other classes, but for patients where drug interactions to other medications isproblematic, and most important for patients who are intolerant to protease inhibitors and NNRTIs due to difficult side effects.